Nanobiotix Sa Stock Shares Owned By Insiders
NANO Stock | EUR 5.88 0.32 5.76% |
Nanobiotix SA fundamentals help investors to digest information that contributes to Nanobiotix's financial success or failures. It also enables traders to predict the movement of Nanobiotix Stock. The fundamental analysis module provides a way to measure Nanobiotix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nanobiotix stock.
Nanobiotix |
Nanobiotix SA Company Shares Owned By Insiders Analysis
Nanobiotix's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Nanobiotix Shares Owned By Insiders | 3.78 % |
Most of Nanobiotix's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nanobiotix SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Competition |
Based on the latest financial disclosure, 3.78% of Nanobiotix SA are shares owned by insiders. This is 75.1% lower than that of the Healthcare sector and 45.38% higher than that of the Drug Manufacturers - Major industry. The shares owned by insiders for all France stocks is 62.54% higher than that of the company.
Nanobiotix Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nanobiotix's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nanobiotix could also be used in its relative valuation, which is a method of valuing Nanobiotix by comparing valuation metrics of similar companies.Nanobiotix is currently under evaluation in shares owned by insiders category among related companies.
Nanobiotix Fundamentals
Return On Equity | -1.99 | |||
Return On Asset | -0.29 | |||
Operating Margin | (17.96) % | |||
Current Valuation | 111.08 M | |||
Shares Outstanding | 34.88 M | |||
Shares Owned By Insiders | 3.78 % | |||
Shares Owned By Institutions | 25.56 % | |||
Price To Earning | (12.17) X | |||
Price To Book | 71.98 X | |||
Price To Sales | 48.04 X | |||
Revenue | 10 K | |||
Gross Profit | 2.65 M | |||
EBITDA | (44.85 M) | |||
Net Income | (47 M) | |||
Cash And Equivalents | 36.2 M | |||
Cash Per Share | 1.85 X | |||
Total Debt | 35.56 M | |||
Debt To Equity | 144.00 % | |||
Current Ratio | 3.68 X | |||
Book Value Per Share | 0.05 X | |||
Cash Flow From Operations | (29.87 M) | |||
Earnings Per Share | (1.20) X | |||
Target Price | 14.9 | |||
Number Of Employees | 103 | |||
Beta | 1.8 | |||
Market Capitalization | 115.07 M | |||
Total Asset | 101.77 M | |||
Retained Earnings | (17 M) | |||
Working Capital | 16 M | |||
Current Asset | 23 M | |||
Current Liabilities | 7 M | |||
Z Score | 1.8 | |||
Net Asset | 101.77 M |
About Nanobiotix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nanobiotix SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nanobiotix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nanobiotix SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nanobiotix SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Nanobiotix Stock refer to our How to Trade Nanobiotix Stock guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for Nanobiotix Stock analysis
When running Nanobiotix's price analysis, check to measure Nanobiotix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobiotix is operating at the current time. Most of Nanobiotix's value examination focuses on studying past and present price action to predict the probability of Nanobiotix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobiotix's price. Additionally, you may evaluate how the addition of Nanobiotix to your portfolios can decrease your overall portfolio volatility.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
CEOs Directory Screen CEOs from public companies around the world |